Measles

Aerosol Delivery Of Vaccine May Be Ideal For Developing Countries

Published in Vaccine Weekly, April 4th, 2001

by N.R. Saltmarsh, staff medical writer - A powder formulation of measles vaccine would be a practical alternative to injectable vaccine in developing countries.

Measles still carries a high mortality rate in the developing world, and vaccine by injection has its own risks, including decreased stability of the vaccine upon reconstitution and possible infection from contaminated needles, noted Cynthia LiCalsi and colleagues, Dura Pharmaceuticals, San Diego, California. An aerosol delivery system, therefore, would be ideal, they think.

"The first challenge in aerosol formulation development is to produce fine particles without damaging the activity of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry